Evidence map›Paper›PMID 34568634›Full record

ArticleCirculation reports2021

Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction.

Yukihito Sato, Takashi Kuragaichi, Shunsuke Saga, Hiroyuki Nakayama, Tomoe Obata, Mitsumasa Watanabe, Kie Fujikura, Masatoki Watanabe, Ken-Ichiro Hata, Hajime Ohgushi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yukihito SatoDepartment of Cardiology, Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
Takashi KuragaichiDepartment of Cardiology, Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
Shunsuke SagaDepartment of Cardiology, Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
Hiroyuki NakayamaDepartment of Cardiology, Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
Tomoe ObataDepartment of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
Mitsumasa WatanabeDepartment of Hematology, Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
Kie FujikuraJapan Tissue Engineering Co., Ltd. (J-TEC) Gamagori Japan.
Masatoki WatanabeJapan Tissue Engineering Co., Ltd. (J-TEC) Gamagori Japan.
Ken-Ichiro HataJapan Tissue Engineering Co., Ltd. (J-TEC) Gamagori Japan.
Hajime OhgushiDepartment of Orthopedic Surgery, Ookuma Hospital Nagoya Japan.
Hyogo Prefectural Amagasaki General Medical Center · JPKuma Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart failureMesenchymal cellRegeneration therapy

Identifiers

PMID34568634
PMCPMC8423613
OpenAlexW3195351480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.